[1]
Rico-Fontalvo, J. et al. 2020. SGLT2 Inhibitors and nephroprotection in diabetic kidney disease: From mechanisms of action to the latest evidence in the literature. Journal of Clinical Nephrology. 4, 2 (Aug. 2020), 044–055. DOI:https://doi.org/10.29328/journal.jcn.1001058.